OrganiGram Holdings Inc. (OGI)
NASDAQ: OGI · IEX Real-Time Price · USD
1.890
+0.020 (1.07%)
At close: Apr 19, 2024, 4:00 PM
1.939
+0.049 (2.59%)
After-hours: Apr 19, 2024, 7:59 PM EDT
OrganiGram Holdings Market Cap
OrganiGram Holdings has a market cap or net worth of $177.85 million as of April 19, 2024. Its market cap has decreased by -5.30% in one year.
Market Cap
177.85M
Enterprise Value
147.54M
1-Year Change
-5.30%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since May 21, 2019, OrganiGram Holdings's market cap has decreased from $1.01B to $177.85M, a decrease of -82.48%. That is a compound annual growth rate of -29.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 19, 2024 | 153.40M | 1.05% |
| Apr 18, 2024 | 151.80M | 2.22% |
| Apr 17, 2024 | 148.50M | -2.69% |
| Apr 16, 2024 | 152.60M | - |
| Apr 15, 2024 | 152.60M | -3.11% |
| Apr 12, 2024 | 157.50M | -5.35% |
| Apr 11, 2024 | 166.40M | -0.95% |
| Apr 10, 2024 | 168.00M | -0.94% |
| Apr 9, 2024 | 169.60M | -4.13% |
| Apr 8, 2024 | 176.90M | 2.79% |
| Apr 5, 2024 | 172.10M | 1.00% |
| Apr 4, 2024 | 170.40M | -8.34% |
| Apr 3, 2024 | 185.90M | 12.26% |
| Apr 2, 2024 | 165.60M | -0.96% |
| Apr 1, 2024 | 167.20M | -4.18% |
| Mar 28, 2024 | 174.50M | -6.33% |
| Mar 27, 2024 | 186.30M | -14.34% |
| Mar 26, 2024 | 217.50M | 6.36% |
| Mar 25, 2024 | 204.50M | -7.38% |
| Mar 22, 2024 | 220.80M | 8.39% |
| Mar 21, 2024 | 203.70M | 3.72% |
| Mar 20, 2024 | 196.40M | 8.99% |
| Mar 19, 2024 | 180.20M | -0.44% |
| Mar 18, 2024 | 181.00M | 7.74% |
| Mar 15, 2024 | 168.00M | 11.26% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 183.68M |
| Semler Scientific | 183.51M |
| Adlai Nortye | 183.49M |
| Generation Bio Co. | 182.81M |
| Outlook Therapeutics | 181.96M |
| Cellectis | 181.67M |
| The Joint | 179.16M |
| Inventiva | 175.92M |